All Rheumatoid arthritis articles
-
Formulary decision guideMethofill® (methotrexate) Self Inject
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Accord UK Ltd in a format developed by Guidelines in Practice . View prescribing and adverse event reporting information here Key points Methofill ® ...
-
Formulary decision guide
Formulary decision guide: Hulio® ▼ (adalimumab biosimilar)
Information intended for healthcare professionals only. This formulary decision guide was developed from content provided by Mylan Ltd in a format developed by Guidelines in Practice. It has been reviewed by a medicines management professional. View prescribing information here
-
Implementing guidelines
People with suspected rheumatoid arthritis must be referred urgently
Dr Louise Warburton reviews the latest recommendations from NICE on the management of rheumatoid arthritis in adults
-
Test and reflect
NICE guideline on rheumatoid arthritis
This CPD activity consists of 5 multiple-choice questions (MCQs) designed to test your knowledge on NICE guideline 100, Rheumatoid arthritis in adults: management.
-
News
Guideline on rheumatoid arthritis published by NICE
NICE has released NICE Guideline (NG) 100 on Rheumatoid arthritis in adults: management, which replaces Clinical Guideline 79.
-
Implementing guidelines
Rheumatic diseases: new guidance aids prescribing of drugs in pregnancy
Dr Ian Giles discusses how the BSR and BHPR guideline on anti-rheumatic drugs in pregnancy and breastfeeding will enable a more consistent approach to prescribing
-
Implementing guidelines
Practical guideline on tocilizumab in RA aids routine clinical care
The British Society for Rheumatology guideline on tocilizumab in rheumatoid arthritis can help commissioners and practitioners alike, says Dr Anshuman P. Malaviya
-
Implementing guidelines
People need to learn to recognise early signs of rheumatoid arthritis
Dr Aneela Mian (left) and Prof David L. Scott highlight recent EULAR guidance updates in the care of people with RA and the importance of prompt referral from primary care
-
NICE quality standard article
Early optimal therapy transforms outcomes in rheumatoid arthritis
Professor Robert Moots (left) and Dr Ashar Ahmed highlight the opportunities and challenges presented by the NICE quality standard for rheumatoid arthritis
-
GMS contract
Rheumatoid arthritis is a new clinical domain for QOF 2013/14
Dr Tim Stokes discusses the revised QOF 2013/14 and the new and revised indicators for COPD, depression, diabetes, hypertension, and rheumatoid arthritis
-
Personal view
NICE updates its guidance on treatment options for RA
Dr Elspeth Wise outlines the requisite criteria for offering biological therapies to patients with rheumatoid arthritis
-
Implementing guidelines
Early GP referral is vital to improvement of outcomes in RA
Drs Caroline Cardy (left) and Simon Bowman discuss the pharmacological treatment pathway for rheumatoid arthritis based on the recent recommendations from NICE
-
Implementing guidelines
BSR and BHPR update eligibility criteria for first biological therapy in RA
Dr Joanna Robson (left) and Dr Raashid Luqmani discuss the recommendations on lowering the DAS-28 threshold and assessing the number of swollen and tender joints
-
Personal view
Guidance provides more choice on treatments for RA
Dr Elspeth Wise discusses the technology appraisals on the use of biological therapies in the management of rheumatoid arthritis
-
Implementing guidelines
NICE recommends early referral for suspected RA
Dr Louise Warburton explains how awareness of the symptoms of rheumatoid arthritis needs to be raised in both healthcare professionals and the public
-
Implementing guidelines
The GP has a key role in referring patients with suspected RA
Dr Raashid Luqmani (left) and Dr Joanna Robson discuss the NICE guideline and the need for a multidisciplinary approach in the management of rheumatoid arthritis
-
Personal view
Early diagnosis of RA can lead to improved outcomes
The NICE guideline on rheumatoid arthritis highlights the importance of referral if synovitis is suspected, says Dr Elspeth Wise
-
Personal view
NICE publishes guidance on use of rituximab for RA
Dr Louise Warburton discusses NICE approval of rituximab for the treatment of patients with severe active rheumatoid arthritis
-
Implementing guidelines
The BSR promotes early referral for rheumatoid arthritis
Dr Raashid Luqmani (left) and Dr John Jackman explain the new BSR guidance, which encourages GPs to refer patients with suspected inflammatory arthritis
-
Implementing guidelines
GPs are still lacking decent guidance for diagnosing RA
Dr Louise Warburton discusses the new BSR guideline on rheumatoid arthritis, and its shortfalls in primary care
